Proliposomes for oral delivery of total biflavonoids extract from Selaginella doederleinii: formulation development, optimization, and in vitro–in vivo characterization

References

• Editorial committee of Chinese Materia Medica. Zhong Hua Ben Cao. Shanghai: Shanghai Science and Technology Press; 1999:711–712.
   Google Scholar
• Saroni ArwaP, Zeraik ML, Ximenes VF, Da Fonseca LM, Bolzani Vda S, Siqueira Silva DH. Redox-active biflavonoids from Garcinia brasiliensis as inhibitors of neutrophil oxidative burst and human erythrocyte membrane damage. J Ethnopharmacol. 2015;174:410–418. doi:10.1016/j.jep.2015.08.04126320685
   PubMed Web of Science ®Google Scholar
• Park NH, Lee CW, Bae JH, Na YJ. Protective effects of amentoflavone on Lamin A-dependent UVB-induced nuclear aberration in normal human fibroblasts. Bioorg Med Chem Lett. 2011;21(21):6482–6484. doi:10.1016/j.bmcl.2011.08.06721917453
   PubMedGoogle Scholar
• Yu S, Yan H, Zhang L, et al. A review on the phytochemistry, pharmacology, and pharmacokinetics of amentoflavone, a naturally-occurring biflavonoid. Molecules. 2017;22(2):299–321. doi:10.3390/molecules22020299
   PubMed Web of Science ®Google Scholar
• Zheng XK, Li YJ, Zhang L, Feng WS, Zhang X. Antihyperglycemic activity of Selaginella tamariscina (Beauv.) Spring. J Ethnopharmacol. 2011;133(2):531–537. doi:10.1016/j.jep.2010.10.02820969941
   PubMed Web of Science ®Google Scholar
• Zheng XK, Zhang L, Wang WW, Wu YY, Zhang QB, Feng WS. Anti-diabetic activity and potential mechanism of total flavonoids of Selaginella tamariscina (Beauv.) Spring in rats induced by high fat diet and low dose STZ. J Ethnopharmacol. 2011;137(1):662–668. doi:10.1016/j.jep.2011.06.01821718776
   PubMed Web of Science ®Google Scholar
• Coulerie P, Nour M, Maciuk A, et al. Structure-activity relationship study of biflavonoids on the Dengue virus polymerase DENV-NS5 RdRp. Planta Med. 2013;79(14):1313–1318. doi:10.1055/s-0033-135067223929244
   PubMed Web of Science ®Google Scholar
• Li S, Zhao M, Li Y, et al. Preparative isolation of six anti-tumour biflavonoids from Selaginella doederleinii Hieron by high-speed counter-current chromatography. Phytochem Anal. 2014;25(2):127–133. doi:10.1002/pca.247824115163
   PubMedGoogle Scholar
• Liu H, Peng H, Ji Z, et al. Reactive oxygen species-mediated mitochondrial dysfunction is involved in apoptosis in human nasopharyngeal carcinoma CNE cells induced by Selaginella doederleinii extract. J Ethnopharmacol. 2011;138(1):184–191. doi:10.1016/j.jep.2011.08.07221924341
   PubMedGoogle Scholar
• Li S, Yao H, Zhao M, Li Y, Huang L, Letters XLJA. Determination of seven biflavones of Selaginella doederleinii by high performance liquid chromatography. Anal Lett 2013;46(18):2835–2845. doi:10.1080/00032719.2013.831426
   Google Scholar
• Lin RC, Skaltsounis AL, Seguin E, Tillequin F, Koch M. Phenolic constituents of Selaginella doederleinii. Planta Med. 1994;60(2):168–170. doi:10.1055/s-2006-95944317236034
   PubMedGoogle Scholar
• Yao H, Chen B, Zhang Y, et al. Analysis of the total biflavonoids extract from Selaginella doederleinii by HPLC-QTOF-MS and its in vitro and in vivo anticancer effects. Molecules. 2017;22(2):325–342. doi:10.3390/molecules22020325
   PubMed Web of Science ®Google Scholar
• Sui Y, Li S, Shi P, et al. Ethyl acetate extract from Selaginella doederleinii Hieron inhibits the growth of human lung cancer cells A549 via caspase-dependent apoptosis pathway. J Ethnopharmacol. 2016;190:261–271. doi:10.1016/j.jep.2016.06.02927292193
   PubMed Web of Science ®Google Scholar
• Sui Y, Yao H, Li S, et al. Delicaflavone induces autophagic cell death in lung cancer via Akt/mTOR/p70S6K signaling pathway. J Mol Med (Berl). 2017;95(3):311–322. doi:10.1007/s00109-016-1487-z27838742
   PubMed Web of Science ®Google Scholar
• Chen B, Wang X, Zou Y, et al. Simultaneous quantification of five biflavonoids in rat plasma by LC-ESI-MS/MS and its application to a comparatively pharmacokinetic study of Selaginella doederleinii Hieron extract in rats. J Pharm Biomed Anal. 2018;149:80–88. doi:10.1016/j.jpba.2017.10.02829101819
   PubMed Web of Science ®Google Scholar
• Yang S, Shi P, Huang X, et al. Pharmacokinetics, tissue distribution and protein binding studies of chrysocauloflavone I in rats. Planta Med. 2016;82(3):217–223. doi:10.1055/s-0035-155815926576031
   PubMedGoogle Scholar
• Luo X, Liu M, Hu L, et al. Targeted delivery of pixantrone to neutrophils by poly(sialic acid)-p-octadecylamine conjugate modified liposomes with improved antitumor activity. Int J Pharm. 2018;547(1–2):315–329. doi:10.1016/j.ijpharm.2018.06.02129886095
   PubMedGoogle Scholar
• Hosny KM, Aljaeid BM. Sildenafil citrate as oral solid lipid nanoparticles: a novel formula with higher bioavailability and sustained action for treatment of erectile dysfunction. Expert Opin Drug Deliv. 2014;11(7):1015–1022. doi:10.1517/17425247.2014.91221224746063
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 1991;51(12):3229–3236. doi:10.1016/b978-0-444-82027-3.50061-42039998
   PubMed Web of Science ®Google Scholar
• Tang J, Sun J, Cui F, Zhang T, Liu X, He Z. Self-emulsifying drug delivery systems for improving oral absorption of ginkgo biloba extracts. Drug Deliv. 2008;15(8):477–484. doi:10.1080/1071754080203908918720135
   PubMed Web of Science ®Google Scholar
• Zhang Y, Che E, Zhang M, et al. Increasing the dissolution rate and oral bioavailability of the poorly water-soluble drug valsartan using novel hierarchical porous carbon monoliths. Int J Pharm. 2014;473(1–2):375–383. doi:10.1016/j.ijpharm.2014.07.02425051114
   PubMed Web of Science ®Google Scholar
• Guan P, Lu Y, Qi J, et al. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Int J Nanomed. 2011;6:965–974. doi:10.2147/IJN.S19259
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145–160. doi:10.1038/nrd163215688077
   PubMed Web of Science ®Google Scholar
• Alexander A, Ajazuddin PRJ, Saraf S, Saraf S. Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives. J Control Release. 2016;241:110–124. doi:10.1016/j.jconrel.2016.09.01727663228
   PubMed Web of Science ®Google Scholar
• Jain S, Harde H, Indulkar A, Agrawal AK. Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration. Nanomedicine. 2014;10(2):431–440. doi:10.1016/j.nano.2013.08.01224036099
   PubMed Web of Science ®Google Scholar
• Hiremath PS, Soppimath KS, Betageri GV. Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine. Int J Pharm. 2009;380(1–2):96–104. doi:10.1016/j.ijpharm.2009.07.00819616608
   PubMed Web of Science ®Google Scholar
• Khan I, Yousaf S, Alhnan MA, Ahmed W, Elhissi A, Jackson MJ. Design characteristics of inhaler devices used for pulmonary delivery of medical aerosols In: Ahmed W, Jackson MJ, editors. Surgical Tools and Medical Devices. Cham: Springer International Publishing; 2016:573–591.
   Google Scholar
• Khan I, Yousaf S, Subramanian S, Albed Alhnan M, Ahmed W, Elhissi A. Proliposome tablets manufactured using a slurry-driven lipid-enriched powders: development, characterization and stability evaluation. Int J Pharm. 2018;538(1–2):250–262. doi:10.1016/j.ijpharm.2017.12.04929337185
   PubMedGoogle Scholar
• Zheng B, Teng L, Xing G, et al. Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: formulation optimization, characterization, oral bioavailability and tissue distribution in rats. EurJ Pharm Sci. 2015;77:254–264. doi:10.1016/j.ejps.2015.06.00726116277
   PubMed Web of Science ®Google Scholar
• Yang G, Zhao Y, Zhang Y, Dang B, Liu Y, Feng N. Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo. Int J Nanomed. 2015;10:6633–6644. doi:10.2147/IJN.S92665
   PubMed Web of Science ®Google Scholar
• Carafa M, Marianecci C, Annibaldi V, Di Stefano A, Sozio P, Santucci E. Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide. Int J Pharm. 2006;325(1–2):155–162. doi:10.1016/j.ijpharm.2006.06.04016884870
   PubMedGoogle Scholar
• Sorndech W, Nakorn KN, Tongta S, Blennow A. Isomalto-oligosaccharides: recent insights in production technology and their use for food and medical applications. Lwt-Food Sci Technol. 2018;95:135–142. doi:10.1016/j.lwt.2018.04.098
   Web of Science ®Google Scholar
• Singh DP, Singh J, Boparai RK, et al. Isomalto-oligosaccharides, a prebiotic, functionally augment green tea effects against high fat diet-induced metabolic alterations via preventing gut dysbacteriosis in mice. Pharmacol Res. 2017;123:103–113. doi:10.1016/j.phrs.2017.06.01528668709
   PubMed Web of Science ®Google Scholar
• He H, Lu Y, Qi J, Zhu Q, Chen Z, Wu W. Adapting liposomes for oral drug delivery. Acta Pharmaceutica Sinica B. 2019;9(1):36–48. doi:10.1016/j.apsb.2018.06.00530766776
   PubMed Web of Science ®Google Scholar
• Liu Y, Luo X, Xu X, Gao N, Liu X. Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes. Int J Pharm. 2017;517(1–2):1–7. doi:10.1016/j.ijpharm.2016.11.05627899320
   PubMed Web of Science ®Google Scholar
• Zhang L, Ren Y, Wang Y, He Y, Feng W, Song C. Pharmacokinetics, distribution and anti-tumor efficacy of liposomal mitoxantrone modified with a luteinizing hormone-releasing hormone receptor-specific peptide. Int J Nanomed. 2018;13:1097–1105. doi:10.2147/IJN.S150512
   PubMed Web of Science ®Google Scholar
• Khayata N, Abdelwahed W, Chehna MF, Charcosset C, Fessi H. Stability study and lyophilization of vitamin E-loaded nanocapsules prepared by membrane contactor. Int J Pharm. 2012;439(1–2):254–259. doi:10.1016/j.ijpharm.2012.09.03223010283
   PubMedGoogle Scholar
• Liu L, Zhang X, Zhang Y, et al. Optimal activation of carboxyl-superparamagnetic iron oxide nanoparticles bioconjugated with antibody using orthogonal array design. J Nanosci Nanotechnol. 2013;13(12):8137–8143. doi:10.1166/jnn.2013.792524266206
   PubMedGoogle Scholar
• Li Y, Tang C, Zhang E, Yang L. Colistin-entrapped liposomes driven by the electrostatic interaction: mechanism of drug loading and in vivo characterization. Int J Pharm. 2016;515(1–2):20–29. doi:10.1016/j.ijpharm.2016.10.00127713028
   PubMedGoogle Scholar
• Katanasaka Y, Kodera Y, Yunokawa M, Kitamura Y, Tamura T, Koizumi F. Synergistic anti-tumor effects of a novel phosphatidyl inositol-3 kinase/mammalian target of rapamycin dual inhibitor BGT226 and gefitinib in non-small cell lung cancer cell lines. Cancer Lett. 2014;347(2):196–203. doi:10.1016/j.canlet.2014.02.02524614285
   PubMedGoogle Scholar
• Zhang H. Thin-film hydration followed by extrusion method for liposome preparation In: Methods in Molecular Biology. Vol. 1522 New York: Humana Press; 2017 17–22. doi:10.1007/978-1-4939-6591-5_227837527
   PubMedGoogle Scholar
• Mann JF, Scales HE, Shakir E, et al. Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity. Methods. 2006;38(2):90–95. doi:10.1016/j.ymeth.2005.11.00216414269
   PubMed Web of Science ®Google Scholar
• Li B, Li S, Tan Y, et al. Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. J Pharm Sci. 2000;89(3):355–364. doi:10.1002/(SICI)1520-6017(200003)89:3<355::AID-JPS7>3.0.CO;2-H10707016
   PubMed Web of Science ®Google Scholar
• Gu Z, Wang Q, Shi Y, et al. Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity. J Control Release. 2018;286:369–380. doi:10.1016/j.jconrel.2018.08.01130096401
   PubMed Web of Science ®Google Scholar
• Wang Q, Wei Q, Yang Q, et al. A novel formulation of [6]-gingerol: proliposomes with enhanced oral bioavailability and antitumor effect. Int J Pharm. 2018;535(1–2):308–315. doi:10.1016/j.ijpharm.2017.11.00629126908
   PubMed Web of Science ®Google Scholar
• Gao D, Tang S, Tong Q. Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery. Int J Nanomed. 2012;7:3517–3526. doi:10.2147/IJN.S31725
   PubMed Web of Science ®Google Scholar
• Zheng B, Yang S, Fan C, et al. Oleic acid derivative of polyethylenimine-functionalized proliposomes for enhancing oral bioavailability of extract of Ginkgo biloba. Drug Deliv. 2016;23(4):1194–1203. doi:10.3109/10717544.2015.110179026635185
   PubMed Web of Science ®Google Scholar
• Venault A, Hsu KJ, Yeh LC, Chinnathambi A, Ho HT, Chang Y. Surface charge-bias impact of amine-contained pseudozwitterionic biointerfaces on the human blood compatibility. Colloids Surf B Biointerfaces. 2017;151:372–383. doi:10.1016/j.colsurfb.2016.12.04028063289
   PubMedGoogle Scholar
• Yadav J, Korzekwa K, Nagar S. Impact of lipid partitioning on the design, analysis, and interpretation of microsomal time-dependent inactivation. Drug Metab Dispos. 2019;47(7):732–742. doi:10.1124/dmd.118.08596931043439
   PubMedGoogle Scholar
• Nguyen TX, Huang L, Gauthier M, Yang G, Wang Q. Recent advances in liposome surface modification for oral drug delivery. Nanomedicine (Lond). 2016;11(9):1169–1185. doi:10.2217/nnm.16.927074098
   PubMed Web of Science ®Google Scholar
• Gagliardi A, Paolino D, Iannone M, Palma E, Fresta M, Cosco D. Sodium deoxycholate-decorated zein nanoparticles for a stable colloidal drug delivery system. Int J Nanomed. 2018;13:601–614. doi:10.2147/IJN.S156930
   PubMed Web of Science ®Google Scholar